See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367083_2023_Sonoma_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001367083, Sonoma Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 16,430,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 320,000 |
| 3 | remainder_Assets | 2,095,000 |
| 4 | LiabilitiesCurrent | 5,819,000 |
| 5 | LiabilitiesNoncurrent | 309,000 |
| 6 | remainder_Liabilities | 4,020,000 |
| 7 | CostOfGoodsAndServicesSold | 8,635,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,755,000 |
| 9 | ResearchAndDevelopmentExpense | 125,000 |
| 10 | remainder_Expenses | -332,000 |
| 11 | remainder_Revenues | 12,628,000 |
| 12 | remainder_NetIncome | 469,000 |
| 13 | remainder_ComprehensiveNetIncome | 267,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 18,845,000 |
| 1 | Liabilities | 10,148,000 |
| 2 | Expenses | 18,183,000 |
| 3 | Revenues | 12,628,000 |
| 4 | StockholdersEquity | 8,697,000 |
| 5 | NetIncome | -5,086,000 |
| 6 | ComprehensiveNetIncome | -4,952,500 |
| 7 | BaseVar | 30,270,000 |
| 8 | EconomicCapitalRatio | 0.690 |